Dr. Michael Baumann
Leitender Arzt
Medizinische Onkologie und Hämatologie · Dept. I
Genetic alterations and MRD refine risk assessment within KMT2A-rearranged B-cell precursor ALL in adult: a GRAALL study.
Kim R, Bergugnat H, Pastoret C, Pasquier F, Raffoux E, Larcher L, Passet M, Grardel N, Delabesse E, Kubetzko S, Caye-Eude A, Meyer C, Marschalek R, Lafage-Pochitaloff M, Thiebaut-Bertrand A, Balsat M, Escoffre-Barbe M, Blum S, Baumann M, Banos A, Straetmans N, Gallego-Hernanz M, Chalandon Y, Graux C, Soulier J, Leguay T, Hunault-Berger M, Huguet F, Lhéritier V, Dombret H, Boissel N, Clappier E. Genetic alterations and MRD refine risk assessment within KMT2A-rearranged B-cell precursor ALL in adult: a GRAALL study. Blood 2023
18.08.2023Genetic alterations and MRD refine risk assessment within KMT2A-rearranged B-cell precursor ALL in adult: a GRAALL study.
18.08.2023Blood 2023
Kim Rathana, Bergugnat Hugo, Pastoret Cedric, Pasquier Florence, Raffoux Emmanuel, Larcher Lise, Passet Marie, Grardel Nathalie, Delabesse Eric, Kubetzko Susanne, Caye-Eude Aurélie, Meyer Claus, Marschalek Rolf, Lafage-Pochitaloff Marina, Thiebaut-Bertrand Anne, Balsat Marie, Escoffre-Barbe Martine, Blum Sabine, Baumann Michael, Banos Anne, Straetmans Nicole, Gallego-Hernanz Maria-Pilar, Chalandon Yves, Graux Carlos, Soulier Jean, Leguay Thibaut, Hunault-Berger Mathilde, Huguet Françoise, Lhéritier Véronique, Dombret Hervé, Boissel Nicolas, Clappier Emmanuelle
High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations.
Fürstenau M, Thus Y, Robrecht S, Mellink C, van der Kevie-Kersemaekers A, Dubois J, von Tresckow J, Patz M, Gregor M, Thornton P, Staber P, Tadmor T, Levin M, da Cunha-Bang C, Schneider C, Poulsen C, Illmer T, Schöttker B, Janssens A, Christiansen I, Noesslinger T, Baumann M, Hebart H, Gaska T, Regelink J, Dompeling E, Lindstrom V, Juliusson G, Widmer A, Goede J, Goldschmidt N, Simon F, De Silva N, Fink A, Fischer K, Wendtner C, Ritgen M, Brüggemann M, Tausch E, Spaargaren M, Eldering E, Stilgenbauer S, Niemann C, Hallek M, Eichhorst B, Kreuzer K, Kater A. High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations. Blood 2023
12.05.2023High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations.
12.05.2023Blood 2023
Fürstenau Moritz, Thus Yvonne J, Robrecht Sandra, Mellink Clemens H M, van der Kevie-Kersemaekers Anne-Marie F, Dubois Julie, von Tresckow Julia, Patz Michaela, Gregor Michael, Thornton Patrick, Staber Philipp B, Tadmor Tamar, Levin Mark-David, da Cunha-Bang Caspar, Schneider Christof, Poulsen Christian Bjørn, Illmer Thomas, Schöttker Björn, Janssens Ann, Christiansen Ilse, Noesslinger Thomas, Baumann Michael, Hebart Holger, Gaska Tobias, Regelink Josien, Dompeling Ellen C, Lindstrom Vesa, Juliusson Gunnar, Widmer Anouk Andrea, Goede Jeroen, Goldschmidt Neta, Simon Florian, De Silva Nisha, Fink Anna Maria, Fischer Kirsten, Wendtner Clemens-Martin, Ritgen Matthias, Brüggemann Monika, Tausch Eugen, Spaargaren Marcel, Eldering Eric, Stilgenbauer Stephan, Niemann Carsten Utoft, Hallek Michael, Eichhorst Barbara, Kreuzer Karl-Anton, Kater Arnon P
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
Eichhorst B, Niemann C, Kater A, Fürstenau M, von Tresckow J, Zhang C, Robrecht S, Gregor M, Juliusson G, Thornton P, Staber P, Tadmor T, Lindstrom V, da Cunha-Bang C, Schneider C, Poulsen C, Illmer T, Schöttker B, Noesslinger T, Janssens A, Christiansen I, Baumann M, Frederiksen H, Klift M, Jäger U, Leys M, Hoogendoorn M, Lotfi K, Hebart H, Gaska T, Koene H, Enggaard L, Goede J, Regelink J, Widmer A, Simon F, De Silva N, Fink A, Bahlo J, Fischer K, Wendtner C, Kreuzer K, Ritgen M, Brüggemann M, Tausch E, Levin M, van Oers M, Geisler C, Stilgenbauer S, Hallek M, GCLLSG, the HOVON and Nordic CLL Study Groups, the SAKK, the Israeli CLL Association, and Cancer Trials Ireland. First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia. N Engl J Med 2023; 388:1739-1754.
11.05.2023First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
11.05.2023N Engl J Med 2023; 388:1739-1754
Eichhorst Barbara, Niemann Carsten Utoft, Kater Arnon P, Fürstenau Moritz, von Tresckow Julia, Zhang Can, Robrecht Sandra, Gregor Michael, Juliusson Gunnar, Thornton Patrick, Staber Philipp B, Tadmor Tamar, Lindstrom Vesa, da Cunha-Bang Caspar, Schneider Christof, Poulsen Christian Bjørn, Illmer Thomas, Schöttker Björn, Noesslinger Thomas, Janssens Ann, Christiansen Ilse, Baumann Michael, Frederiksen Henrik, Klift Marjolein van der, Jäger Ulrich, Leys Maria B L, Hoogendoorn Mels, Lotfi Kourosh, Hebart Holger, Gaska Tobias, Koene Harry, Enggaard Lisbeth, Goede Jereon, Regelink Josien, Widmer Anouk Andrea, Simon Florian, De Silva Nisha, Fink Anna Maria, Bahlo Jasmin, Fischer Kirsten, Wendtner Clemens-Martin, Kreuzer Karl A, Ritgen Matthias, Brüggemann Monika, Tausch Eugen, Levin Mark-David, van Oers Marinus, Geisler Christian, Stilgenbauer Stephan, Hallek Michael, GCLLSG, the HOVON and Nordic CLL Study Groups, the SAKK, the Israeli CLL Association, and Cancer Trials Ireland
Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia: a GRAALL-2005 study.
Orvain C, Chantepie S, Thomas X, Escofrre-Barbe M, Huguet F, Desbrosses Y, Guillerm G, Uzunov M, Leguay T, Barbieux S, Vey N, Chevallier P, Malfuson J, Lepretre S, Baumann M, Aykut M, Chaib A, Joris M, Zerazhi H, Stussi G, Chapiro J, Berthon C, Bonmati C, Jourdan E, Carp D, Marcais A, Gallego-Hernanz M, Vaida I, Bilger K, Villate A, Pasquier F, Chalandon Y, Maury S, Lhéritier V, Ifrah N, Dombret H, Boissel N, Hunault-Berger M. Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia: a GRAALL-2005 study. Haematologica 2023
09.03.2023Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia: a GRAALL-2005 study.
09.03.2023Haematologica 2023
Orvain Corentin, Chantepie Sylvain, Thomas Xavier, Escofrre-Barbe Martine, Huguet Françoise, Desbrosses Yohan, Guillerm Gaelle, Uzunov Madalina, Leguay Thibaut, Barbieux Sarah, Vey Norbert, Chevallier Patrice, Malfuson Jean-Valere, Lepretre Stephane, Baumann Michael, Aykut Murat, Chaib Abdelaziz, Joris Magalie, Zerazhi Hacene, Stussi Georg, Chapiro Jacques, Berthon Celine, Bonmati Caroline, Jourdan Eric, Carp Diana, Marcais Amb Roise, Gallego-Hernanz Maria-Pilar, Vaida Iona, Bilger Karin, Villate Alban, Pasquier Florence, Chalandon Yves, Maury Sébastien, Lhéritier Véronique, Ifrah Norbert, Dombret Hervé, Boissel Nicolas, Hunault-Berger Mathilde
Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial
Benz R, O'Meara Stern A, Cantoni N, Bargetzi M, Bianchi-Papina E, Rossi D, Passweg J, Lohri A, Berardi S, Feller A, Rauch D, Blum S, Mey U, Arn K, Andres M, Pabst T, Baumann M, Novak U, Hitz F, Hess U, Zenhaeusern R, Chalandon Y, Stussi G. Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial. Blood Adv 2020; 4:3699-3707.
11.08.2020Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial
11.08.2020Blood Adv 2020; 4:3699-3707
Benz Rudolf, O'Meara Stern Alix, Cantoni Nathan, Bargetzi Mario, Bianchi-Papina Elena, Rossi Davide, Passweg Jakob, Lohri Andreas, Berardi Simona, Feller Anita, Rauch Daniel, Blum Sabine, Mey Ulrich, Arn Kornelius, Andres Martin, Pabst Thomas, Baumann Michael, Novak Urban, Hitz Felicitas, Hess Urs, Zenhaeusern Reinhard, Chalandon Yves, Stussi Georg
Vitamin D levels in Swiss breast cancer survivors
Baumann M, Templeton A, Ruhstaller T, Riesen W, Mark M, Klingbiel D, Hochstrasser A, Dietrich D, Dani S, Thürlimann B. Vitamin D levels in Swiss breast cancer survivors. Swiss Med Wkly 2018; 148:w14576.
29.01.2018Vitamin D levels in Swiss breast cancer survivors
29.01.2018Swiss Med Wkly 2018; 148:w14576
Baumann Michael, Templeton Arnoud J, Ruhstaller Thomas, Riesen Walter F, Mark Michael Thomas, Klingbiel Dirk, Hochstrasser Andreas, Dietrich Daniel, Dani Sergio Ulhoa, Thürlimann Beat
Efficacy of phosphatidylinositol-3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cells.
Göckeritz E, Kerwien S, Baumann M, Wigger M, Vondey V, Neumann L, Landwehr T, Wendtner C, Klein C, Liu N, Hallek M, Frenzel L, Krause G. Efficacy of phosphatidylinositol-3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cells. Int J Cancer 2015; 137:2234-42.
12.05.2015Efficacy of phosphatidylinositol-3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cells.
12.05.2015Int J Cancer 2015; 137:2234-42
Göckeritz Elisa, Kerwien Susan, Baumann Michael, Wigger Marion, Vondey Verena, Neumann Lars, Landwehr Thomas, Wendtner Clemens M, Klein Christian, Liu Ningshu, Hallek Michael, Frenzel Lukas P, Krause Günter
Massive human rivaroxaban overdose.
Lehmann T, Hofer K, Baumann M, Hasler K, Ceschi A, Kupferschmidt H, Rohde G, Korte W. Massive human rivaroxaban overdose. Thromb Haemost 2014; 112:834-6.
24.07.2014Massive human rivaroxaban overdose.
24.07.2014Thromb Haemost 2014; 112:834-6
Lehmann Thomas, Hofer Katharina E, Baumann Michael, Hasler Karin, Ceschi Alessandro, Kupferschmidt Hugo, Rohde Gabriele, Korte Wolfgang
Cross-sectional study of self-reported physical activity, eating habits and use of complementary medicine in breast cancer survivors
Templeton A, Thürlimann B, Baumann M, Mark M, Stoll S, Schwizer M, Dietrich D, Ruhstaller T. Cross-sectional study of self-reported physical activity, eating habits and use of complementary medicine in breast cancer survivors. BMC cancer 2013; 13:153.
25.03.2013Cross-sectional study of self-reported physical activity, eating habits and use of complementary medicine in breast cancer survivors
25.03.2013BMC cancer 2013; 13:153
Templeton Arnoud J, Thürlimann Beat, Baumann Michael, Mark Michael, Stoll Sarah, Schwizer Madeleine, Dietrich Daniel, Ruhstaller Thomas
Thrombophilidiagnostik - Entscheidungshilfe in komplexen Risikosituationen
Baumann M, Korte W. Thrombophilidiagnostik - Entscheidungshilfe in komplexen Risikosituationen. Cardiovasc 2012; 6:4-6.
01.11.2012Thrombophilidiagnostik - Entscheidungshilfe in komplexen Risikosituationen
01.11.2012Cardiovasc 2012; 6:4-6
Baumann Michael, Korte Wolfgang
B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides.
Schwamb J, Feldhaus V, Baumann M, Patz M, Brodesser S, Brinker R, Claasen J, Pallasch C, Hallek M, Wendtner C, Frenzel L. B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides. Blood 2012; 120:3978-85.
27.08.2012B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides.
27.08.2012Blood 2012; 120:3978-85
Schwamb Janine, Feldhaus Valeska, Baumann Michael, Patz Michaela, Brodesser Susanne, Brinker Reinhild, Claasen Julia, Pallasch Christian P, Hallek Michael, Wendtner Clemens-Martin, Frenzel Lukas P
Trastuzumab Treatment beyond Progression in Advanced Breast Cancer: Patterns of Care in Six Swiss Breast Cancer Centers
Huober J, Widmer I, von Rohr L, Müller A, von Moos R, Güth U, Aebi S, Rochlitz C, Baumann M, Thürlimann B. Trastuzumab Treatment beyond Progression in Advanced Breast Cancer: Patterns of Care in Six Swiss Breast Cancer Centers. Oncology 2011; 81:160-166.
28.10.2011Trastuzumab Treatment beyond Progression in Advanced Breast Cancer: Patterns of Care in Six Swiss Breast Cancer Centers
28.10.2011Oncology 2011; 81:160-166
Huober Jens, Widmer Isabelle, von Rohr Lukas, Müller Andreas, von Moos Roger, Güth Uwe, Aebi Stefan, Rochlitz Christoph, Baumann Michael, Thürlimann Beat
Chronische Lymphatische Leukämie (CLL) - Von Faszination und Meilensteinen
Baumann M. Chronische Lymphatische Leukämie (CLL) - Von Faszination und Meilensteinen. info@onkologie 2011:6-10.
01.08.2011Chronische Lymphatische Leukämie (CLL) - Von Faszination und Meilensteinen
01.08.2011info@onkologie 2011:6-10
Baumann Michael
Langerhans cell histiocytosis with central nervous system involvement-complete response to 2-chlorodeoxyadenosine after failure of tyrosine kinase inhibitor therapies with sorafenib and imatinib
Baumann M, Cerny T, Sommacal A, Köberle D. Langerhans cell histiocytosis with central nervous system involvement-complete response to 2-chlorodeoxyadenosine after failure of tyrosine kinase inhibitor therapies with sorafenib and imatinib. Hematol Oncol 2011
05.07.2011Langerhans cell histiocytosis with central nervous system involvement-complete response to 2-chlorodeoxyadenosine after failure of tyrosine kinase inhibitor therapies with sorafenib and imatinib
05.07.2011Hematol Oncol 2011
Baumann Michael, Cerny Thomas, Sommacal Andreas, Köberle Dieter
Brustzentrum Kantonsspital St. Gallen – von der Multidisziplinarität zur patientinnenzentrierten interdisziplinären Betriebsorganisation
Baumann M, Thürlimann B, Ruhstaller T. Brustzentrum Kantonsspital St. Gallen – von der Multidisziplinarität zur patientinnenzentrierten interdisziplinären Betriebsorganisation. Breast Care 2010; 5:188-191.
08.06.2010Brustzentrum Kantonsspital St. Gallen – von der Multidisziplinarität zur patientinnenzentrierten interdisziplinären Betriebsorganisation
08.06.2010Breast Care 2010; 5:188-191
Baumann Michael, Thürlimann Beat, Ruhstaller Thomas
Neue Behandlungsoptionen beim metatstasierten Kolorektalkarzinom
Baumann M, Weder P, Köberle D. Neue Behandlungsoptionen beim metatstasierten Kolorektalkarzinom - Bewertung der aktuellen Studeienresultate und Konsequenzen. Schweizer Zeitschrift für Onkologie 2009:14-19.
01.01.2009Neue Behandlungsoptionen beim metatstasierten Kolorektalkarzinom
01.01.2009Schweizer Zeitschrift für Onkologie 2009:14-19
Baumann Michael, Weder Patrik, Köberle Dieter